BUNGELTD Quarterly Depreciation, Depletion and Amortization in USD from Q1 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Bungeltd quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2010 to Q1 2023.
  • Bungeltd Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $102M, unchanged year-over-year.
  • Bungeltd annual Depreciation, Depletion and Amortization for 2022 was $408M, a 3.77% decline from 2021.
  • Bungeltd annual Depreciation, Depletion and Amortization for 2021 was $424M, a 2.53% decline from 2020.
  • Bungeltd annual Depreciation, Depletion and Amortization for 2020 was $435M, a 20.6% decline from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $102M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q1 2022 $420M $102M -$4M -3.77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $424M $107M -$5M -4.46% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 $429M $105M -$1M -0.94% Jul 1, 2021 Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $430M $106M +$2M +1.92% Apr 1, 2021 Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $428M $106M -$7M -6.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $435M $112M -$7M -5.88% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $442M $106M -$28M -20.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $470M $104M -$52M -33.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $522M $113M -$26M -18.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $548M $119M -$40M -25.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $588M $134M -$25M -15.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $613M $156M -$6M -3.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $619M $139M -$3M -2.11% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $622M $159M -$2M -1.24% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $624M $159M -$7M -4.22% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $631M $162M +$10M +6.58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $621M $142M +$12M +9.23% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $609M $161M +$17M +11.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $592M $166M +$17M +11.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $575M $152M +$11M +7.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $564M $130M +$17M +15% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $547M $144M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $149M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $141M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $113M -$7M -5.83% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 $120M -$4M -3.23% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q1 2014 $124M +$3M +2.48% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q1 2013 $571M $121M +$1M +0.83% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 $570M $156M +$28M +21.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $542M $150M -$1M -0.66% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $543M $144M +$1M +0.7% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $542M $120M +$16M +15.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $526M $128M +$11M +9.4% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $515M $151M +$40M +36% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $475M $143M +$30M +26.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $445M $104M +$2M +1.96% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q4 2010 $443M $117M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $111M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $113M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
Q1 2010 $102M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.